Corporate News Report
Agios Pharmaceuticals (AGIO)
Trading performance
- The stock closed at USD 37.00 on Monday, 26 November 2026, down 0.51 % from the previous close.
- At 12:58 PM Central Europe time, the price was USD 37.00.
- The current supply of Agios shares is 59.7 million.
- Market capitalization is USD 2.2 billion.
- Trading volume over the last 24 hours was USD 34 million.
- Since the end of October, the share price has increased 12.46 %.
- The 200‑day simple moving average stands at USD 31.50.
- The 52‑week high was USD 46.00 on 18 November 2025.
- The 52‑week low was USD 22.24 on 19 November 2025.
Related Stock Movements (Last 24 Hours)
| Ticker | 24‑hour change | Current price (USD) | Market cap (USD) | P/E ratio |
|---|---|---|---|---|
| POWI | –0.3 % | 46.98 | 2.6 billion | 106.15 |
| VECO | +2.21 % | 42.06 | 2.6 billion | 115.41 |
| BHFAO | –0.39 % | 12.88 | 2.6 billion | 4.83 |
| RH | –1.94 % | 137.43 | 2.6 billion | 24.21 |
Company Overview
Agios Pharmaceuticals, Inc. is a biotechnology firm headquartered in Cambridge, Massachusetts, United States. The company specializes in the discovery and development of therapeutics that target cancer metabolism. Its pipeline focuses on glycolysis, fatty acid metabolism, and autophagy pathways, which are critical for cancer cell growth and survival.
